119 related articles for article (PubMed ID: 10406649)
1. From histamine to imidazolylalkyl-sulfonamides: the design of a novel series of histamine H3-receptor antagonists.
Tozer MJ; Harper EA; Kalindjian SB; Pether MJ; Shankley NP; Watt GF
Bioorg Med Chem Lett; 1999 Jul; 9(13):1825-30. PubMed ID: 10406649
[TBL] [Abstract][Full Text] [Related]
2. 4-Chlorobenzyl sulfonamide and sulfamide derivatives of histamine homologues: the design of potent histamine H3 receptor antagonists.
Tozer MJ; Buck IM; Cooke T; Kalindjian SB; McDonald IM; Pether MJ; Steel KI
Bioorg Med Chem Lett; 1999 Nov; 9(21):3103-8. PubMed ID: 10560733
[TBL] [Abstract][Full Text] [Related]
3. Novel H3 receptor antagonists. Sulfonamide homologs of histamine.
Wolin R; Connolly M; Afonso A; Hey JA; She H; Rivelli MA; Willams SM; West RE
Bioorg Med Chem Lett; 1998 Aug; 8(16):2157-62. PubMed ID: 9873505
[TBL] [Abstract][Full Text] [Related]
4. 4-[(1H-imidazol-4-yl) methyl] benzamidines and benzylamidines: novel antagonists of the histamine H3 receptor.
Aslanian R; Brown JE; Shih NY; wa Mutahi M; Green MJ; She S; Del Prado M; West R; Hey J
Bioorg Med Chem Lett; 1998 Aug; 8(16):2263-8. PubMed ID: 9873525
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of histamine H
Watanabe M; Kobayashi T; Ito Y; Fukuda H; Yamada S; Arisawa M; Shuto S
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3630-3633. PubMed ID: 30385161
[TBL] [Abstract][Full Text] [Related]
6. Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H3-receptor antagonists.
Stark H; Ligneau X; Sadek B; Ganellin CR; Arrang JM; Schwartz JC; Schunack W
Bioorg Med Chem Lett; 2000 Oct; 10(20):2379-82. PubMed ID: 11055360
[TBL] [Abstract][Full Text] [Related]
7. Non-imidazole histamine H3 ligands. Part III. New 4-n-propylpiperazines as non-imidazole histamine H3-antagonists.
Walczyński K; Zuiderveld OP; Timmerman H
Eur J Med Chem; 2005 Jan; 40(1):15-23. PubMed ID: 15642406
[TBL] [Abstract][Full Text] [Related]
8. Ligands of the histamine H3-receptor: new potent antagonists of the 2-thioimidazole type.
Plazzi PV; Mor M; Bordi F; Silva C; Rivara S; Caretta A; Ballabeni V; Impicciatore M; Vitali T
Farmaco; 1997 May; 52(5):295-302. PubMed ID: 9274000
[TBL] [Abstract][Full Text] [Related]
9. Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.
Letavic MA; Stocking EM; Barbier AJ; Bonaventure P; Boggs JD; Lord B; Miller KL; Wilson SJ; Carruthers NI
Bioorg Med Chem Lett; 2007 Sep; 17(17):4799-803. PubMed ID: 17616397
[TBL] [Abstract][Full Text] [Related]
10. 4-Alkynylphenyl imidazolylpropyl ethers as selective histamine H3-receptor antagonists with high oral central nervous system activity.
Krause M; Ligneau X; Stark H; Garbarg M; Schwartz JC; Schunack W
J Med Chem; 1998 Oct; 41(21):4171-6. PubMed ID: 9767653
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and histamine H3 receptor activity of 4-(n-alkyl)-1H-imidazoles and 4-(omega-phenylalkyl)-1H-imidazoles.
De Esch IJ; Gaffar A; Menge WM; Timmerman H
Bioorg Med Chem; 1999 Dec; 7(12):3003-9. PubMed ID: 10658607
[TBL] [Abstract][Full Text] [Related]
12. Novel naphthyridines are histamine H3 antagonists and serotonin reuptake transporter inhibitors.
Letavic MA; Keith JM; Ly KS; Barbier AJ; Boggs JD; Wilson SJ; Lord B; Lovenberg TW; Carruthers NI
Bioorg Med Chem Lett; 2007 May; 17(9):2566-9. PubMed ID: 17307358
[TBL] [Abstract][Full Text] [Related]
13. Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists.
Berlin M; Ting PC; Vaccaro WD; Aslanian R; McCormick KD; Lee JF; Albanese MM; Mutahi MW; Piwinski JJ; Shih NY; Duguma L; Solomon DM; Zhou W; Sher R; Favreau L; Bryant M; Korfmacher WA; Nardo C; West RE; Anthes JC; Williams SM; Wu RL; Susan She H; Rivelli MA; Corboz MR; Hey JA
Bioorg Med Chem Lett; 2006 Feb; 16(4):989-94. PubMed ID: 16297617
[TBL] [Abstract][Full Text] [Related]
14. H3-receptor antagonists: synthesis and structure-activity relationships of para- and meta-substituted 4(5)-phenyl-2-[[2-[4(5)-imidazolyl]ethyl]thio]imidazoles.
Mor M; Bordi F; Silva C; Rivara S; Crivori P; Plazzi PV; Ballabeni V; Caretta A; Barocelli E; Impicciatore M; Carrupt PA; Testa B
J Med Chem; 1997 Aug; 40(16):2571-8. PubMed ID: 9258364
[TBL] [Abstract][Full Text] [Related]
15. Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitors.
Keith JM; Gomez LA; Wolin RL; Barbier AJ; Wilson SJ; Boggs JD; Mazur C; Fraser IC; Lord B; Aluisio L; Lovenberg TW; Carruthers NI
Bioorg Med Chem Lett; 2007 May; 17(9):2603-7. PubMed ID: 17317177
[TBL] [Abstract][Full Text] [Related]
16. Convenient procedures for synthesis of ciproxifan, a histamine H3-receptor antagonist.
Stark H
Arch Pharm (Weinheim); 2000 Sep; 333(9):315-6. PubMed ID: 11039189
[TBL] [Abstract][Full Text] [Related]
17. omega-(Imidazol-4-yl)alkane-1-sulfonamides: a new series of potent histamine H(3) receptor antagonists.
Tozer MJ; Buck IM; Cooke T; Kalindjian SB; Pether MJ; Steel KI
Bioorg Med Chem; 2002 Feb; 10(2):425-32. PubMed ID: 11741790
[TBL] [Abstract][Full Text] [Related]
18. Non-imidazole histamine NO-donor H3-antagonists.
Tosco P; Bertinaria M; Di Stilo A; Cena C; Fruttero R; Gasco A
Farmaco; 2005; 60(6-7):507-12. PubMed ID: 15927183
[TBL] [Abstract][Full Text] [Related]
19. Theophylline derivatives as potential histamine H3-receptor antagonists.
Kieć-Kononowicz K; Cegła MT
Pharmazie; 1998 Aug; 53(8):518-21. PubMed ID: 9741061
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and structure-activity relationships of acetylene-based histamine H3 receptor antagonists.
Ali SM; Tedford CE; Gregory R; Handley MK; Yates SL; Hirth WW; Phillips JG
J Med Chem; 1999 Mar; 42(5):903-9. PubMed ID: 10072687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
